Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer

NCT02347332 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

459

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent or Metastatic Head and Neck Carcinoma

Interventions

DRUG: Vinflunine
DRUG: Methotrexate

Sponsor

Pierre Fabre Medicament